Form 4: BeiGene Director Sells Shares
Insider Transaction (Form 4)
Xiaodong Wang, a Director of BeiGene, Ltd., sold 38,287 shares of common stock on September 8, 2026.
Summary
- Open-market sale: disposed of 1,181 American Depositary Shares at $345.38 ($407,897) on September 8, 2026; holds 6,079 after (Direct).
- Open-market sale: disposed of 2,841 American Depositary Shares at $346.16 ($983,433) on September 8, 2026; holds 3,238 after (Direct).
- Open-market sale: disposed of 1,517 American Depositary Shares at $347.39 ($526,993) on September 8, 2026; holds 1,721 after (Direct).
- Open-market sale: disposed of 1,721 American Depositary Shares at $348.01 ($598,930) on September 8, 2026 (Direct).
- Option exercise/conversion: acquired 31,027 American Depositary Shares at $36.90 ($1,144,896) on September 8, 2026; holds 31,027 after (Direct).
- Open-market sale: disposed of 7,492 American Depositary Shares at $348.31 ($2,609,573) on September 8, 2026; holds 23,535 after (Direct).
- Open-market sale: disposed of 10,688 American Depositary Shares at $349.28 ($3,733,141) on September 8, 2026; holds 12,847 after (Direct).
- Open-market sale: disposed of 6,569 American Depositary Shares at $350.27 ($2,300,951) on September 8, 2026; holds 6,278 after (Direct).
- Open-market sale: disposed of 6,278 American Depositary Shares at $351.25 ($2,205,174) on September 8, 2026 (Direct).
- Option exercise/conversion: disposed of 403,351 Share Option (Right to Buy) on September 8, 2026; holds 1,210,079 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $13,366,092 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Xiaodong Wang — Director, Other (Chair, Scientific Advisory Brd)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | American Depositary Shares | 1,181 | $345 | $407.9K | 6,079 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 2,841 | $346 | $983.4K | 3,238 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 1,517 | $347 | $527.0K | 1,721 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 1,721 | $348 | $598.9K | 0 |
| 2026-09-08 | Option exercise/conversion | American Depositary Shares | 31,027 | $37 | $1.1M | 31,027 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 7,492 | $348 | $2.6M | 23,535 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 10,688 | $349 | $3.7M | 12,847 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 6,569 | $350 | $2.3M | 6,278 |
| 2026-09-08 | Open-market sale | American Depositary Shares | 6,278 | $351 | $2.2M | 0 |
| 2026-09-08 | Option exercise/conversion | Share Option (Right to Buy) | 403,351 | — | — | 1,210,079 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (1,181 shares) |
| 2026-09-08 | Open-market sale (2,841 shares) |
| 2026-09-08 | Open-market sale (1,517 shares) |
| 2026-09-08 | Open-market sale (1,721 shares) |
| 2026-09-08 | Option exercise/conversion (31,027 shares) |
| 2026-09-08 | Open-market sale (7,492 shares) |
| 2026-09-08 | Open-market sale (10,688 shares) |
| 2026-09-08 | Open-market sale (6,569 shares) |
| 2026-09-08 | Open-market sale (6,278 shares) |
| 2026-09-08 | Option exercise/conversion (403,351 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Xiaodong Wang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.